Literature DB >> 20956146

Epidemiology of COPD.

C Raherison1, P-O Girodet.   

Abstract

Chronic obstructive pulmonary disease (COPD) is responsible for early mortality, high death rates and significant cost to health systems. The projection for 2020 indicates that COPD will be the third leading cause of death worldwide (from sixth in 1990) and fifth leading cause of years lost through early mortality or handicap (disability-adjusted life years) (12th in 1990). Active smoking remains the main risk factor, but other factors are becoming better known, such as occupational factors, infections and the role of air pollution. Prevalence of COPD varies according to country, age and sex. This disease is also associated with significant comorbidities. COPD is a disorder that includes various phenotypes, the continuum of which remains under debate. The major challenge in the coming years will be to prevent onset of smoking along with early detection of the disease in the general population.

Entities:  

Mesh:

Year:  2009        PMID: 20956146     DOI: 10.1183/09059180.00003609

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  125 in total

1.  Aging-Related Considerations When Evaluating the Forced Expiratory Volume in 1 Second (FEV1) Over Time.

Authors:  Carlos A Vaz Fragoso; Gail McAvay; Peter H Van Ness; E Jeffrey Metter; Luigi Ferrucci; H Klar Yaggi; John Concato; Thomas M Gill
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-11-02       Impact factor: 6.053

2.  Temperament and character profiles of male COPD patients.

Authors:  Hasan Kahraman; Fatma Ozlem Orhan; Mustafa Haki Sucakli; Ali Ozer; Nurhan Koksal; Bilal Sen
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 3.  Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).

Authors:  Han Ni; Aung Htet; Soe Moe
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

4.  Respiratory symptoms, spirometric respiratory impairment, and respiratory disease in middle-aged and older persons.

Authors:  Brian S Marcus; Gail McAvay; Thomas M Gill; Carlos A Vaz Fragoso
Journal:  J Am Geriatr Soc       Date:  2015-01-30       Impact factor: 5.562

5.  Comparison of Effects of Endurance and Strength Training Programs in Patients with COPD.

Authors:  Michael J Berry; Katherine L Sheilds; Norman E Adair
Journal:  COPD       Date:  2018-04-16       Impact factor: 2.409

6.  Respiratory impairment and mortality in older persons: a novel spirometric approach.

Authors:  Carlos A Vaz Fragoso; Thomas M Gill; Gail McAvay; Henry Klar Yaggi; Peter H Van Ness; John Concato
Journal:  J Investig Med       Date:  2011-10       Impact factor: 2.895

7.  Development and validation of a patient reported outcome instrument for chronic obstructive pulmonary diseases.

Authors:  Jian-sheng Li; Ming-hang Wang; Xue-qing Yu; Su-yun Li; Yang Xie
Journal:  Chin J Integr Med       Date:  2014-09-24       Impact factor: 1.978

8.  Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans.

Authors:  Michelle K McHugh; Matthew B Schabath; Chung-Han Ho; Mei Liu; Anthony M D'Amelio; Anthony J Greisinger; George L Delclos; Margaret R Spitz; Carol J Etzel
Journal:  J Immigr Minor Health       Date:  2013-10

Review 9.  Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.

Authors:  Farzaneh Sanei; Tom Wilkinson
Journal:  Ther Adv Respir Dis       Date:  2016-05-18       Impact factor: 4.031

10.  Cigarette smoking, cadmium exposure, and zinc intake on obstructive lung disorder.

Authors:  Yu-Sheng Lin; James L Caffrey; Man-Huei Chang; Nicole Dowling; Jou-Wei Lin
Journal:  Respir Res       Date:  2010-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.